Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Laromestrocel by Longeveron for Hypoplastic Left Heart Syndrome: Likelihood of Approval
Laromestrocel is under clinical development by Longeveron and currently in Phase II for Hypoplastic Left Heart Syndrome. According to GlobalData,...
Data Insights
Laromestrocel by Longeveron for Alzheimer's Disease: Likelihood of Approval
Laromestrocel is under clinical development by Longeveron and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase II...